You are here: Industry Insights > Bayer

News List

Bayer-Monsanto deal one step closer, after EU nod pharmafile
March 23, 2018
The merger between Bayer and agricultural giant, Monsanto, is inching closer to completion after the EU Commission won EU antitrust approval.
Bayer HealthCare's faltering even before Monsanto enters the fold fiercepharma
March 01, 2018
Industry watchers were worried about Bayer neglecting its healthcare division after the company chased down a megamerger with agrochemical giant Monsanto. But that deal hasn’t even closed yet, and healthcare sales are already showing cause for concern.
Bayer announces publication of larotrectinib data in The New England Journal of Medicine worldpharmanews
February 28, 2018
Bayer announced the publication in The New England Journal of Medicine (NEJM) of larotrectinib data for the treatment of pediatric and adult patients whose tumors harbor Neurotrophic Tyrosine Receptor Kinase (NTRK) gene fusions.
GSK, Bayer top global ranking for online messaging fiercepharma
February 09, 2018
GlaxoSmithKline is the first pharma in almost a decade to top Bowen Craggs & Co.'s online excellence ranking.
FDA report reaffirms safety profile and effectiveness of Bayer's Xarelto® in routine clinical practi worldpharmanews
January 17, 2018
A report from the U.S. Food and Drug Administration (FDA) published in Pharmacoepidemiology & Drug Safety confirms the safety profile and effectiveness of Xarelto® (rivaroxaban) in people with atrial fibrillation (AF).
Bayer's $175 million pneumonia drug fails at phase 3 pharmafile
November 28, 2017
Bayer has been hit by the news that its latest effort in the pneumonia space failed at the Phase 3 stage
Grants4Apps Singapore inventors’ digital prototypes help elderly take their medicines as prescribed biospectrumasia
November 23, 2017
Innovative digital concepts addressed a significant health challenge as patient adherence to long-term medications is only 50%.
After penning Loxo deal, Bayer signs another $1B R&D pact fiercebiotech
November 21, 2017
Bayer has signed a new and potentially major research pact with Japan’s PeptiDream, marking the second big biobucks deal of its kind for the German pharma in the past week.
Bayer’s Stivarga wins NICE approval for GIST pharmatimes
November 21, 2017
Bayer’s Stivarga has been recommended by the National Institute for Health and Care Excellence as a treatment for some patients with gastrointestinal stromal tumours (GIST).
Bayer and Loxo Oncology to develop and commercialize two novel oncology therapies selectively target worldpharmanews
November 20, 2017
Bayer reached an exclusive global agreement with Loxo Oncology, Inc., a biopharmaceutical company based in Stamford, CT, to develop and commercialize the larotrectinib (LOXO-101) and LOXO-195

Previous page 1 2 3 4 5 6 7 8 9 10 ... 20 21 Next page